Vendor review
Shandong Shengyuan Peptide Technology reviews
Shandong Shengyuan Peptide Technology reviews from 33 independent lab tests (Tirzepatide, Retatrutide and GHK-Cu): grade A, purity and fill accuracy. Is Shandong Shengyuan Peptide Technology legit? See what its vials showed.
What the lab tests show
33 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Jul 30, 2026 | Tirzepatide | 99.8 % | 8.1 mg of 10 mg (-19 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 10 mg | Fail | View | |
| May 13, 2026 | Tirzepatide | 99.9 % | 30 mg of 30 mg (0 %) | Pass | View |
| Mar 29, 2026 | Tirzepatide | 99.8 % | 30.4 mg of 30 mg (1 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 5.06 mg of 5 mg (1 %) | Pass | View |
| Mar 18, 2026 | Tirzepatide | 99.9 % | 23.2 mg of 20 mg (16 %) | Pass | View |
| Feb 26, 2026 | GHK-Cu | 78.91 % | 44.4 mg of 100 mg (-56 %) | Pass | View |
| Feb 25, 2026 | Tirzepatide | 99.9 % | 20.7 mg of 20 mg (3 %) | Pass | View |
| Feb 23, 2026 | Tirzepatide | 99.74 % | 6.91 mg of 10 mg (-31 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.9 % | 16.4 mg of 10 mg (64 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.9 % | 15.8 mg of 10 mg (58 %) | Pass | View |
| Feb 9, 2026 | Retatrutide | 99.9 % | 21 mg of 20 mg (5 %) | Pass | View |
| Jan 29, 2026 | Tirzepatide | 10 mg | Fail | View | |
| Jan 26, 2026 | Retatrutide | 99.8 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.8 % | 5.15 mg of 5 mg (3 %) | Pass | View |
| Jan 26, 2026 | Tirzepatide | 99.8 % | 26.4 mg of 20 mg (32 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jan 22, 2026 | Tirzepatide | 99.9 % | 23.5 mg of 20 mg (18 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.7 % | 9.7 mg of 10 mg (-3 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.6 % | 33.8 mg of 30 mg (13 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.95 % | 9.96 mg of 10 mg (0 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 98.67 % | 15.1 mg of 15 mg (1 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.95 % | 28.9 mg of 30 mg (-4 %) | Pass | View |
| Dec 6, 2025 | GHK-Cu | 99.74 % | 50.8 mg of 50 mg (2 %) | Pass | View |
| Dec 5, 2025 | Retatrutide | 99.6 % | 20.3 mg of 20 mg (2 %) | Pass | View |
| Nov 25, 2025 | Tirzepatide | 98.7 % | 4.78 mg of 5 mg (-4 %) | Pass | View |
| Nov 18, 2025 | Tirzepatide | 99.94 % | 30.1 mg of 30 mg (0 %) | Pass | View |
| Nov 17, 2025 | Tirzepatide | 99.65 % | 15.1 mg of 15 mg (1 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 99.42 % | 14.5 mg of 15 mg (-3 %) | Pass | View |
| Nov 17, 2025 | GHK-Cu | 99.95 % | 51.3 mg of 50 mg (3 %) | Pass | View |
| Oct 17, 2025 | Tirzepatide | 99.95 % | 22.4 mg of 20 mg (12 %) | Pass | View |
| Oct 17, 2025 | Tirzepatide | 99.95 % | 30.5 mg of 30 mg (2 %) | Pass | View |
| Oct 17, 2025 | Tirzepatide | 99.95 % | 9.26 mg of 10 mg (-7 %) | Pass | View |
What Shandong Shengyuan Peptide Technology sells
No current listings on record.
About Shandong Shengyuan Peptide Technology
86 199 3069 5612